Direct Thrombin Inhibitors: Appraisal of the Antithrombotic/ Hemorrhagic Balance
- 1 June 1997
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 78 (1), 357-363
- https://doi.org/10.1055/s-0038-1657552
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Potential advantages of direct-acting thrombin inhibitorsCoronary Artery Disease, 1996
- Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393The Lancet, 1996
- Novel Antithrombotic Drugs in DevelopmentDrugs, 1995
- Rebound Increase in Thrombin Generation and Activity After Cessation of Intravenous Heparin in Patients With Acute Coronary SyndromesCirculation, 1995
- Persistent thrombin generation in humans during specific thrombin inhibition with hirudin.Circulation, 1994
- Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)Circulation, 1994
- A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trialJournal of the American College of Cardiology, 1994
- Thrombin inhibitors in unstable angina: Rebound or continuation of angina after argatroban withdrawal?Journal of the American College of Cardiology, 1993
- Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisJournal of the American College of Cardiology, 1993
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992